Panbela Therapeutics News

Panbela Therapeutics Announces Delay of Expected Data From Pancreatic Cancer Treatment Trial

Seeking AlphaApr 22 09:18 ET

Panbela Therapeutics Updates ASPIRE Trial Timeline

TipRanksApr 22 08:12 ET

Express News | Panbela Therapeutics Inc: Interim Data Analysis for Aspire Trial Pushed to Q1 2025

Moomoo 24/7Apr 22 08:04 ET

Panbela Applies to List on CBOE

By Stephen Nakrosis Panbela Therapeutics, whose shares were recently delisted from the Nasdaq, said Thursday it will seek to list on the US Equity Listings Tier II Chicago Board of Options Exchange.

WSJApr 18 17:23 ET

Panbela Therapeutics, Recently Delisted From Nasdaq and Now on OTCQB, to Seek CBOE Stock Listing

Panbela Therapeutics, Recently Delisted From Nasdaq and Now on OTCQB, to Seek CBOE Stock Listing

Dow JonesApr 18 16:48 ET

Panbela Therapeutics Files for Stock and Warrant Offering

Panbela Therapeutics Files for Stock and Warrant Offering

Dow JonesApr 18 16:46 ET

Express News | Panbela Announces Poster Presentation at American Association for Cancer Research:

Moomoo 24/7Apr 18 08:00 ET

Panbela Therapeutics Shifts From Nasdaq to OTCQB Market

TipRanksApr 17 08:52 ET

Panbela Announces Transfer to OTCQB Market

Panbela Therapeutics, Inc. (OTCQB: PBLA), today announced that its common stock has been approved for quotation on the OTCQB market. Panbela's common stock will be eligible for quotation on the OTCQB starting on April 17, 2024, under the symbol "PBLA."

GlobeNewswireApr 16 17:29 ET

Panbela Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Panbela Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow JonesApr 2 08:56 ET

Express News | HC Wainwright & Co. Maintains Buy on Panbela Therapeutics, Lowers Price Target to $5

Moomoo 24/7Apr 2 08:49 ET

Analysts Offer Insights on Healthcare Companies: Aldeyra Therapeutics (ALDX), Carisma Therapeutics (CARM) and Panbela Therapeutics (OtherPBLA)

TipRanksApr 2 06:20 ET

Express News | Roth MKM Maintains Buy on Panbela Therapeutics, Maintains $25 Price Target

Moomoo 24/7Mar 27 11:59 ET

Earnings Call Summary | Panbela Therapeutics(PBLA.US) Q4 2023 Earnings Conference

The following is a summary of the Panbela Therapeutics, Inc. (PBLA) Q4 2023 Earnings Call Transcript:Financial Performance:Panbela's general and administrative expenses were down to $0.9 million due t

moomoo AIMar 26 22:21 ET · Conference Call

Press Release: Panbela Provides Business Update and Reports Q4 and FY 2024 Financial Results

Panbela Therapeutics, Inc. (NASDAQ:PBLA) today provides a business update and reports financial results for the quarter and full year ended December 31, 2023.

Dow JonesMar 26 16:57 ET

Recap: Panbela Therapeutics Q4 Earnings

Panbela Therapeutics (OTC:PBLA) reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:10 PM.Here's what investors need to know about the announcement.EarningsPanbela Therapeutics missed es

BenzingaMar 26 16:55 ET

Panbela Therapeutics GAAP EPS of -$65.90 Beats by $151.10

Seeking AlphaMar 26 16:14 ET

Earnings Preview: Panbela Therapeutics

Panbela Therapeutics (NASDAQ:PBLA) is set to give its latest quarterly earnings report on Tuesday, 2024-03-26. Here's what investors need to know before the announcement.Analysts estimate that Panbela

BenzingaMar 25 11:01 ET

Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024

Panbela Therapeutics, Inc. (NASDAQ:PBLA), ("Panbela"), a clinical stage company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs, today announced that it will host a conference call on March 26, 2024, at 4:30 PM Eastern Time to discuss results for its fourth quarter and year ended December 31, 2023.

GlobeNewswireMar 12 16:15 ET

Nasdaq to Delist Panbela Therapeutics Over Equity Shortfall

InvestingMar 7 06:52 ET